Pluristem Therapeutics Inc
PSTI
Market Cap$40.85M
Close$
$2.11
111.1% upside
Current Fair Value
111.1% upsideUndervalued by 111.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $40.85 Million |
|---|---|
| Enterprise Value | $47.92 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.77 |
| Beta | 1.91 |
| Outstanding Shares | 32,261,628 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.56 |
|---|---|
| PEG | 1.91 |
| Price to Sales | - |
| Price to Book Ratio | 1.0 |
| Enterprise Value to Revenue | 204.79 |
| Enterprise Value to EBIT | -1.03 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Pluristem Therapeutics Inc
CEO: Yaky Yanay